These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 39206530)

  • 21. Complement involvement in sickle cell disease.
    Meuleman MS; Roumenina LT; Grunenwald A
    Presse Med; 2023 Dec; 52(4):104205. PubMed ID: 37972851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sickle Cell Disease and Thromboembolism: New Insights on the Pathophysiology, Diagnosis, and Treatment.
    Dobie G
    Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic potential of probiotics in gut microbial homeostasis and Rheumatoid arthritis.
    Balasundaram D; Veerasamy V; Sylvia Singarayar M; Neethirajan V; Ananth Devanesan A; Thilagar S
    Int Immunopharmacol; 2024 Aug; 137():112501. PubMed ID: 38885604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.
    Deux JF; Audard V; Brugières P; Habibi A; Manea EM; Guillaud-Danis C; Godeau B; Galactéros F; Stehlé T; Lang P; Grimbert P; Audureau E; Rahmouni A; Bartolucci P
    Am J Kidney Dis; 2017 Jan; 69(1):51-59. PubMed ID: 27663041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do we have to consider acidosis induced by exercise as deleterious in sickle cell disease?
    Chatel B; Messonnier LA; Bendahan D
    Exp Physiol; 2018 Sep; 103(9):1213-1220. PubMed ID: 30024072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbiome dynamics in rheumatic diseases.
    Wang Y; Wang Z; Lu Q
    Curr Opin Rheumatol; 2024 Mar; 36(2):134-141. PubMed ID: 37976078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative blood transfusions for sickle cell disease.
    Estcourt LJ; Kimber C; Trivella M; Doree C; Hopewell S
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003149. PubMed ID: 32614473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presentation of Acute Pancreatitis in Sickle Cell Disease Patients: A Single Hospital Experience.
    Al-Hindi S; Khalaf Z; Al-Sousi AN
    Afr J Paediatr Surg; 2024 Jul; 21(3):151-154. PubMed ID: 39162749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review/overview of pain in sickle cell disease.
    Ballas SK; Darbari DS
    Complement Ther Med; 2020 Mar; 49():102327. PubMed ID: 32147066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unraveling the gut microbiome's contribution to pancreatic ductal adenocarcinoma: mechanistic insights and therapeutic perspectives.
    Tabrizi E; Pourteymour Fard Tabrizi F; Mahmoud Khaled G; Sestito MP; Jamie S; Boone BA
    Front Immunol; 2024; 15():1434771. PubMed ID: 39044834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucosal microbiota characterization in gastric cancer identifies immune-activated-related transcripts relevant gastric microbiome signatures.
    Qian C; Hui J; Peng Z; Sun X; Zhang J
    Front Immunol; 2024; 15():1435334. PubMed ID: 39376571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut microbiome and non-alcoholic fatty liver disease.
    Purohit A; Alam MJ; Kandiyal B; Shalimar ; Das B; Banerjee SK
    Prog Mol Biol Transl Sci; 2022; 191(1):187-206. PubMed ID: 36270678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sickle Cell Disease: Bone, Joint, Muscle, and Motor Complications.
    Benenson I; Porter S
    Orthop Nurs; 2018; 37(4):221-227. PubMed ID: 30028422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Intestinal Microbiota in Children With Sickle Cell Disease.
    Karahan F; Yilmaz SS; Bayrakdar F; Tezol Ö; Kuyucu N; Kiliç S; Türkegün M; Ünal S
    J Pediatr Hematol Oncol; 2023 Oct; 45(7):e904-e909. PubMed ID: 37526399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insights into Gut Dysbiosis: Inflammatory Diseases, Obesity, and Restoration Approaches.
    Acevedo-Román A; Pagán-Zayas N; Velázquez-Rivera LI; Torres-Ventura AC; Godoy-Vitorino F
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology and recent therapeutic insights of sickle cell disease.
    Shah F; Dwivedi M
    Ann Hematol; 2020 May; 99(5):925-935. PubMed ID: 32157419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insights into the skin microbiome of sickle cell disease leg ulcers.
    Byeon J; Blizinsky KD; Persaud A; Findley K; Lee JJ; Buscetta AJ; You S; Bittinger K; Minniti CP; Bonham VL; Grice EA
    Wound Repair Regen; 2021 Sep; 29(5):801-809. PubMed ID: 33964094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crises in Sickle Cell Disease.
    Novelli EM; Gladwin MT
    Chest; 2016 Apr; 149(4):1082-93. PubMed ID: 26836899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The gut microbiome's role in the development, maintenance, and outcomes of sepsis.
    Adelman MW; Woodworth MH; Langelier C; Busch LM; Kempker JA; Kraft CS; Martin GS
    Crit Care; 2020 Jun; 24(1):278. PubMed ID: 32487252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the fecal microbiota in inflammatory bowel disease.
    Khalaf R; Sciberras M; Ellul P
    Eur J Gastroenterol Hepatol; 2024 Nov; 36(11):1249-1258. PubMed ID: 38973540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.